vs
Digimarc CORP（DMRC）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
Arcus Biosciences, Inc.的季度营收约是Digimarc CORP的1.2倍（$11.0M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -963.6%，领先916.4%），Digimarc CORP同比增速更快（2.9% vs -52.2%），Digimarc CORP自由现金流更多（$895.0K vs $-121.0M），过去两年Arcus Biosciences, Inc.的营收复合增速更高（4.9% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
DMRC vs RCUS — 直观对比
营收规模更大
RCUS
是对方的1.2倍
$8.9M
营收增速更快
DMRC
高出55.1%
-52.2%
净利率更高
DMRC
高出916.4%
-963.6%
自由现金流更多
DMRC
多$121.9M
$-121.0M
两年增速更快
RCUS
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $11.0M |
| 净利润 | $-4.2M | $-106.0M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -1036.4% |
| 净利率 | -47.2% | -963.6% |
| 营收同比 | 2.9% | -52.2% |
| 净利润同比 | 51.4% | -12.8% |
| 每股收益（稀释后） | $-0.18 | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCRCUS
| Q4 25 | $8.9M | $11.0M | ||
| Q3 25 | $7.6M | $6.0M | ||
| Q2 25 | $8.0M | $8.0M | ||
| Q1 25 | $9.4M | $8.0M | ||
| Q4 24 | $8.7M | $23.0M | ||
| Q3 24 | $9.4M | $7.0M | ||
| Q2 24 | $10.4M | $11.0M | ||
| Q1 24 | $9.9M | $10.0M |
净利润DMRCRCUS
| Q4 25 | $-4.2M | $-106.0M | ||
| Q3 25 | $-8.2M | $-135.0M | ||
| Q2 25 | $-8.2M | $0 | ||
| Q1 25 | $-11.7M | $-112.0M | ||
| Q4 24 | $-8.6M | $-94.0M | ||
| Q3 24 | $-10.8M | $-92.0M | ||
| Q2 24 | $-9.3M | $-93.0M | ||
| Q1 24 | $-10.3M | $-4.0M |
毛利率DMRCRCUS
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCRCUS
| Q4 25 | -48.2% | -1036.4% | ||
| Q3 25 | -109.7% | -2366.7% | ||
| Q2 25 | -105.2% | -100.0% | ||
| Q1 25 | -128.9% | -1525.0% | ||
| Q4 24 | -105.1% | -447.8% | ||
| Q3 24 | -120.4% | -1500.0% | ||
| Q2 24 | -96.2% | -963.6% | ||
| Q1 24 | -109.2% | -160.0% |
净利率DMRCRCUS
| Q4 25 | -47.2% | -963.6% | ||
| Q3 25 | -106.9% | -2250.0% | ||
| Q2 25 | -102.6% | — | ||
| Q1 25 | -125.2% | -1400.0% | ||
| Q4 24 | -99.9% | -408.7% | ||
| Q3 24 | -113.9% | -1314.3% | ||
| Q2 24 | -89.3% | -845.5% | ||
| Q1 24 | -104.0% | -40.0% |
每股收益（稀释后）DMRCRCUS
| Q4 25 | $-0.18 | $-0.88 | ||
| Q3 25 | $-0.38 | $-1.27 | ||
| Q2 25 | $-0.38 | $0.00 | ||
| Q1 25 | $-0.55 | $-1.14 | ||
| Q4 24 | $-0.40 | $-1.07 | ||
| Q3 24 | $-0.50 | $-1.00 | ||
| Q2 24 | $-0.43 | $-1.02 | ||
| Q1 24 | $-0.50 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $222.0M |
| 总债务越低越好 | — | $99.0M |
| 股东权益账面价值 | $40.2M | $631.0M |
| 总资产 | $53.0M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资DMRCRCUS
| Q4 25 | $12.9M | $222.0M | ||
| Q3 25 | $12.6M | $238.0M | ||
| Q2 25 | $16.1M | $248.0M | ||
| Q1 25 | $21.6M | $192.0M | ||
| Q4 24 | $28.7M | $150.0M | ||
| Q3 24 | $33.7M | $201.0M | ||
| Q2 24 | $41.5M | $156.0M | ||
| Q1 24 | $48.9M | $185.0M |
总债务DMRCRCUS
| Q4 25 | — | $99.0M | ||
| Q3 25 | — | $98.0M | ||
| Q2 25 | — | $97.0M | ||
| Q1 25 | — | $48.0M | ||
| Q4 24 | — | $48.0M | ||
| Q3 24 | — | $47.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DMRCRCUS
| Q4 25 | $40.2M | $631.0M | ||
| Q3 25 | $41.4M | $436.0M | ||
| Q2 25 | $46.5M | $549.0M | ||
| Q1 25 | $50.0M | $531.0M | ||
| Q4 24 | $61.4M | $485.0M | ||
| Q3 24 | $70.2M | $565.0M | ||
| Q2 24 | $77.2M | $635.0M | ||
| Q1 24 | $84.5M | $707.0M |
总资产DMRCRCUS
| Q4 25 | $53.0M | $1.1B | ||
| Q3 25 | $55.4M | $974.0M | ||
| Q2 25 | $60.7M | $1.1B | ||
| Q1 25 | $66.5M | $1.2B | ||
| Q4 24 | $75.8M | $1.1B | ||
| Q3 24 | $85.0M | $1.3B | ||
| Q2 24 | $93.4M | $1.2B | ||
| Q1 24 | $99.7M | $1.3B |
负债/权益比DMRCRCUS
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-121.0M |
| 自由现金流率自由现金流/营收 | 10.0% | -1100.0% |
| 资本支出强度资本支出/营收 | 1.1% | 9.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCRCUS
| Q4 25 | $991.0K | $-120.0M | ||
| Q3 25 | $-2.6M | $-97.0M | ||
| Q2 25 | $-4.7M | $-133.0M | ||
| Q1 25 | $-5.5M | $-132.0M | ||
| Q4 24 | $-4.2M | $-100.0M | ||
| Q3 24 | $-7.1M | $26.0M | ||
| Q2 24 | $-6.8M | $-94.0M | ||
| Q1 24 | $-8.4M | $-2.0M |
自由现金流DMRCRCUS
| Q4 25 | $895.0K | $-121.0M | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-5.5M | $-133.0M | ||
| Q4 24 | $-4.2M | $-101.0M | ||
| Q3 24 | $-7.2M | $25.0M | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $-8.5M | $-6.0M |
自由现金流率DMRCRCUS
| Q4 25 | 10.0% | -1100.0% | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -59.1% | -1662.5% | ||
| Q4 24 | -49.1% | -439.1% | ||
| Q3 24 | -75.7% | 357.1% | ||
| Q2 24 | -66.1% | — | ||
| Q1 24 | -85.8% | -60.0% |
资本支出强度DMRCRCUS
| Q4 25 | 1.1% | 9.1% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | 0.6% | 12.5% | ||
| Q4 24 | 0.2% | 4.3% | ||
| Q3 24 | 0.7% | 14.3% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 1.1% | 40.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
